NervGen Pharma Valuation
| NGEN Stock | CAD 3.00 0.13 4.15% |
At this time, the firm appears to be overvalued. NervGen Pharma Corp secures a last-minute Real Value of C$2.35 per share. The latest price of the firm is C$3.0. Our model forecasts the value of NervGen Pharma Corp from analyzing the firm fundamentals such as Shares Owned By Insiders of 22.91 %, return on equity of -2.3, and Current Valuation of 190.05 M as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting NervGen Pharma's valuation include:
Price Book 22.9812 | Enterprise Value 190 M | Enterprise Value Ebitda (4.54) |
Overvalued
Today
Please note that NervGen Pharma's price fluctuation is dangerous at this time. Calculation of the real value of NervGen Pharma Corp is based on 3 months time horizon. Increasing NervGen Pharma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the NervGen stock is determined by what a typical buyer is willing to pay for full or partial control of NervGen Pharma Corp. Since NervGen Pharma is currently traded on the exchange, buyers and sellers on that exchange determine the market value of NervGen Stock. However, NervGen Pharma's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.0 | Real 2.35 | Hype 2.96 |
The intrinsic value of NervGen Pharma's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence NervGen Pharma's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of NervGen Pharma Corp helps investors to forecast how NervGen stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of NervGen Pharma more accurately as focusing exclusively on NervGen Pharma's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use NervGen Pharma's intrinsic value based on its ongoing forecasts of NervGen Pharma's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against NervGen Pharma's closest peers.
NervGen Pharma Cash |
|
NervGen Valuation Trend
Analysing the historical paterns of NervGen Pharma's enterprise value and its market capitalization is a good way to estimate and gauge the value of NervGen Pharma Corp over time and is usually enough for investors to make rational market timing decisions.
NervGen Pharma Total Value Analysis
NervGen Pharma Corp is now forecasted to have takeover price of 190.05 M with market capitalization of 210.92 M, debt of 15.25 M, and cash on hands of 8.27 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the NervGen Pharma fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
190.05 M | 210.92 M | 15.25 M | 8.27 M |
NervGen Pharma Asset Utilization
One of the ways to look at asset utilization of NervGen is to check how much profit was generated for every dollar of assets it reports. NervGen Pharma Corp secures a negative usage of assets of -0.53 %, losing C$0.005314 for each dollar of assets held by the firm. Inadequate asset utilization conveys that the company is being less effective with each dollar of assets it secures. Strictly speaking, asset utilization of NervGen Pharma Corp shows how discouraging it operates for each dollar spent on its assets.NervGen Pharma Ownership Allocation
NervGen Pharma Corp maintains a total of 70.31 Million outstanding shares. NervGen Pharma Corp holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.NervGen Pharma Profitability Analysis
Net Loss for the year was (22.38 M) with profit before overhead, payroll, taxes, and interest of 0.About NervGen Pharma Valuation
Our relative valuation model uses a comparative analysis of NervGen Pharma. We calculate exposure to NervGen Pharma's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of NervGen Pharma's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -103.6 K | -98.4 K |
Additional Tools for NervGen Stock Analysis
When running NervGen Pharma's price analysis, check to measure NervGen Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NervGen Pharma is operating at the current time. Most of NervGen Pharma's value examination focuses on studying past and present price action to predict the probability of NervGen Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NervGen Pharma's price. Additionally, you may evaluate how the addition of NervGen Pharma to your portfolios can decrease your overall portfolio volatility.